You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

38 search results for: pediatric

Evaluating the Responses to Biologic Therapies in Children With Atopic Dermatitis
expert video

Evaluating the Responses to Biologic Therapies in Children With Atopic Dermatitis

Dermatology
Dr. Amy Paller shares her opinion on practical considerations for evaluating response during treatment with biologics in children with atopic dermatitis.
View more
The Implications of Sweat Duct Dysfunction and the Microbial Dysbiosis in AD
expert video

The Implications of Sweat Duct Dysfunction and the Microbial Dysbiosis in AD

Dermatology
Dr. Lisa Beck talks about sweat duct dysfunction and the impact of S. aureus colonization.
View more
The Role of Epithelial Barrier Components in AD: Insights and Implications
expert video

The Role of Epithelial Barrier Components in AD: Insights and Implications

Dermatology
Dr. Lisa Beck explains the role of epithelial barrier components and barrier disruption in AD.
View more
The Burden of Atopic Dermatitis in Children – Skin Infections and More Severe Disease
expert video

The Burden of Atopic Dermatitis in Children – Skin Infections and More Severe Disease

Dermatology
Dr. Mark Koh talks about skin infections and their impact on disease severity.
View more
The Burden of Atopic Dermatitis in Children – Identifying Persistent Disease
expert video

The Burden of Atopic Dermatitis in Children – Identifying Persistent Disease

Dermatology
Dr. Mark Koh explains how to identify children with persistent disease.
View more
Key Type 2 Cytokines Impact Skin Structural Proteins in Atopic Dermatitis
expert video

Key Type 2 Cytokines Impact Skin Structural Proteins in Atopic Dermatitis

Dermatology
Dr. Stephan Weidinger talks about type 2 cytokines and their role in barrier deficiency.
View more
Key Type 2 Cytokines Impact the Skin Microbiome in Atopic Dermatitis
expert video

Key Type 2 Cytokines Impact the Skin Microbiome in Atopic Dermatitis

Dermatology
Dr. Stephan Weidinger explains how type 2 cytokines impact the skin microbiome in AD.
View more
The Potential Impact of Early Intervention in Atopic Dermatitis in Children
expert video

The Potential Impact of Early Intervention in Atopic Dermatitis in Children

Dermatology
Dr. Amy Paller shares her opinion of whether treatment is needed when children might outgrow their disease.
View more
The Burden of Atopic Dermatitis in Children – The Impact of Persistent Disease
expert video

The Burden of Atopic Dermatitis in Children – The Impact of Persistent Disease

Dermatology
Dr. Mark Koh explains how age at disease onset is linked to persistent disease.
View more
The Multidimensional Impact of Atopic Dermatitis on Children and Their Caregivers
expert video

The Multidimensional Impact of Atopic Dermatitis on Children and Their Caregivers

Dermatology
Discover the multidimensional impact of pediatric atopic dermatitis on children and caregivers – a soundbite from the Expert Lounge Canada 2022.
View more
Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​ - Panel Discussion
expert video

Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​ - Panel Discussion

Dermatology
Panel discussion exploring how itch differs across AD, PN, and CSU, and how it affects pediatric patients with AD.
View more
ADVENT On Air - Dermatology
Podcast

ADVENT On Air | Expert Discussions in Dermatology

Dermatology
Listen to the latest updates in type 2 inflammatory science and associated skin diseases, brought to you by leading dermatology experts in the field. ADVENT On Air podcasts feature scientific conversations that explore new research into the pathophysiology, clinical features, and disease burden for a range of dermatological diseases linked to type 2 inflammation, including atopic dermatitis (AD) and prurigo nodularis (PN). Hear new insights revealed through expert-led conversations below or in your preferred podcast app.

View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: South AfricaChange country/region